C-reactive protein and venous thromboembolism: A prospective investigation in the ARIC cohort
Year: 2009
Type: article
Study design: Observational Study
Abstract: The role of inflammation in the causation of venous thromboembolism (VTE) is uncertain. In 10,505 participants of the Atherosclerosis Risk in Communities (ARIC) Study, we assessed the association of the systemic inflammation marker, elevated C-reactive protein (CRP), with incidence of VTE (n=221) over a median of 8.3 years of follow-up. Adjusted for age, race, and sex, the hazard ratios of VTE across quintiles of CRP were 1.0, 1.61, 1.16, 1.56, and 2.31 (p for trend p<0.0007). For CRP above the upper 10 percentile (> or = 8.55 mg/L), compared with the lowest 90% of CRP values, the hazard ratio of VTE was 2.07 (95% CI 1.47, 2.94). Further adjustment for baseline hormone replacement therapy, diabetes, and body mass index attenuated the hazard ratios only slightly. For example, the adjusted hazard ratio of VTE was 1.76 (95% CI 1.23, 2.52) for CRP above versus below the 90(th) percentile. In conclusion, this prospective, population-based study suggests elevated CRP is independently associated with increased risk of VTE.
Source: Thrombosis and Haemostasis
DOI: 10.1160/th09-04-0274
Language: English
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1325221871, Atherosclerosis Risk in Communities Study (ARIC), CCSP FIELD CENTER, COMMUNITY AND COHORT SURVEILLANCE PROGRAM, CENTRAL HEMOSTATIS LABORATORY FOR CCSP, G3236609591, G390162502, Atherosclerosis Risk in Communities Study (ARIC), G5451084504, Epidemiology of Venous Thrombosis and Pulmonary Embolism, Atherosclerosis Risk in Communities Study (ARIC), G6203107232, Longitudinal Study of Predictors and Consequences of Chronic Kidney Disease, G812579647, G8486527673, Atherosclerosis Risk in Communities Study (ARIC)
OpenAlex ID: W1987598636
